Cite
Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study
MLA
Cardiovasculaire Epi Team 5, et al. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395291076&authtype=sso&custid=ns315887.
APA
Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Smit, M., van Zoest, R. A., Nichols, B. E., Vaartjes, I., Smit, C., van der Valk, M., van Sighem, A. I., Wit, F. W. N. M., Hallett, T. B., Reiss, P., & Netherlands ATHENA observational HIV cohort. (2018). Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.
Chicago
Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Mikaela Smit, Rosan A van Zoest, Brooke E Nichols, Ilonca Vaartjes, et al. 2018. “Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395291076&authtype=sso&custid=ns315887.